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Background: Chronic kidney disease is an increasing health problem worldwide and in its 
final stage (stage V) can only be treated by renal replacement therapy, mostly hemodialysis. 
Hemodialysis has a major influence on the everyday life of patients and many patients report 
dissatisfaction with treatment. Little is known about which aspects of treatment are considered 
important by hemodialysis patients. The objective of this study was to rate the relative importance 
of different outcomes for hemodialysis patients and to analyze whether the relative importance 
differed among subgroups of patients.
Patients and methods: Within the framework of a yearly questionnaire which is distributed 
among patients receiving hemodialysis by the largest hemodialysis provider in Germany, we 
assessed the relative importance of 23 outcomes as rated on a discrete visual analog scale. 
Descriptive statistics were used to rank the outcomes. Subgroup analyses were performed using 
Mann–Whitney U or Kruskal–Wallis tests.
Results: Questionnaires of 4,518 hemodialysis patients were included in the analysis. 
The three most important outcomes were safety of treatment, health-related quality of life, and 
satisfaction with care. Further important outcomes were hospital stays, accompanying symptoms, 
hemodialysis duration, and the improvement or preservation of a good emotional state. Age, 
profession, and education had the strongest influence on relevant differences of preferences for 
outcomes; no relevant influence of sex or comorbidity was observed.
Conclusion: Outcomes concerning the delivery or provision of care and aspects influencing 
quality of life are rated by patients to be at least as important as clinical outcomes. Many of 
the outcomes judged to be important by the patients are not regularly considered in research, 
evaluation studies, or quality programs.
Keywords: patient-centered outcomes, preference elicitation, chronic disease, patient-centered 
research, rating scale
Introduction
Chronic kidney disease (CKD) is an increasing health problem worldwide.1,2 The 
increase seems eminent when looking at just a few risk factors for CKD stage V: 
hypertension, increasing age, diabetes, or obesity.3 In Germany, the prevalence of 
dialysis patients increased from 769 to 808 cases per million between 2005 and 2006.4 
A high prevalence of CKD is also observable in other European countries.5 In the US, 
the prevalence of patients with CKD increased from 290 to 1,738 cases per million 
between 1980 and 2009 and more than 870,000 patients were being treated in 2009.2 
In stage V, CKD can only be treated with renal replacement therapy, either dialysis or 
transplantation.6 About 65% of patients receive hemodialysis, 25% receive a kidney 
transplant, and 10% are treated by peritoneal dialysis.3 Patients treated with hemodialysis 
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not only have a low health-related quality of life7 but experi-
ence mortality rates of 15%–20% each year.8 
Hemodialysis patients often feel dissatisfied with their 
treatment, and report how profound the impact of the disease 
and the treatment is on their lives.9–11 Beyond their imme-
diate influence on the well-being of the patients, aspects 
such as patient perception of physician support or satisfac-
tion with care affect the adherence and the cooperation of 
patients,5,12,13 which have been identified as major determi-
nants of life expectancy and morbidity.10,14,15 Knowledge 
about attitudes and experiences of patients is essential to be 
able to better understand the reasons for nonadherence and 
dissatisfaction. 
Over the past years, patient-centered care has gained 
importance, but researchers and practitioners have not fully 
incorporated patient-centered methods in their work.16,17 
A key aspect of patient-centered evaluation requires the 
involvement of patients in all aspects of research, includ-
ing the selection of outcomes. Considering patient-reported 
outcomes is one way to incorporate important aspects for 
patients in research, even though other outcomes which are 
not patient reported can also be of relevance to patients.18 
Many instruments have been used to assess the preferences of 
outcomes so far; among the most common  are conjoint analy-
sis methods, rating scales, or utility assessment methods.19 
And although the measurement of patient-reported outcomes 
has gained importance over the past 10–15 years, still 75% 
of US drug labels do not include patient-reported outcomes. 
And even in those drug labels evaluating patient-reported 
outcomes, various aspects of the patient experience with 
care are not considered.20
There are indications of a divergence between the out-
comes that are routinely measured in research and clinical 
practice and the preferences of patients with advanced kidney 
disease.9,21,22 The choice of outcomes used in the evaluation 
of treatments determines which information patients have 
available to decide which treatment they would prefer. The 
omission of outcomes which are relevant for patients can 
have direct consequences on their decision-making ability.20 
So far, patient preferences have rarely been considered in 
choosing patient-relevant outcomes for research in the area 
of CKD stage V.23
The objective of this study was to compare the relative 
importance of a large set of outcomes that may be of relevance 
to patients receiving a hemodialysis treatment for CKD. 
We also analyzed to what extent the relative importance 
of outcomes differed between predefined subgroups of 
patients.
Methods
identifying the outcomes and developing 
the questions
To identify relevant outcomes, we held a group discussion 
with patients from a regional self-help group (Sektion Nieder-
rhein, Interessengemeinschaft Niere e.v. [lower-Rhine area 
branch, the kidney interest group]). The group discussion took 
place during a regular group meeting which seven patients 
attended. The purpose of the study was explained to the 
patients and they were asked to talk about all hemodialysis 
treatment aspects they would consider important. Notes of the 
key issues were taken and condensed into 23 outcomes with 
the support of an additional patient who was not part of the 
group discussion. A pretest to assess the comprehensibility of 
the questions and the completeness of the outcomes used was 
conducted with five patients, who were not part of the self-help 
group discussion but were recruited in a hemodialysis clinic. 
The five patients were asked to comment on the 23 outcomes 
we established with input from the group discussion. We were 
especially interested in whether any relevant outcomes were 
missing and if they understood the meaning of the outcomes. 
All five patients were satisfied with the range of outcomes, 
reported that they understood the phrasing of the outcomes, 
and did not suggest further outcomes to be included. 
We decided to use a simple rating scale in the form of 
a discrete visual analog scale (this scale resembles a Likert 
scale but differs slightly as it uses two phrased anchors, “not 
important” and “very important”). A review showed that rat-
ing scales can include a larger number of outcomes compared 
to more complex methods such as conjoint analysis. It also 
highlighted that patients find it relatively easy to answer these 
kinds of questions and the response rate of valid answers was 
higher than with more complex methods.19 A complete list 
of the 23 outcomes and their phrasing in the questionnaire 
(translated from German) is shown in Table 1. The discrete 
visual analog scale consisted of nine categories, ranging 
from not important (1) to very important (9), and was scored 
according to the Likert scale values.
Population
The Kuratorium fuer Dialyse und Nierentransplantation e.V. 
(KfH) is the largest provider of hemodialysis in Germany. 
It comprises more than 200 units treating approximately 
18,000 patients annually. As part of its quality assurance 
program, Quality in Nephrology (QiN), KfH sends a yearly 
questionnaire to its patients.24
Within the scope of a research collaboration with the KfH, 
we were permitted to add our questions to the questionnaire 
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in the fourth quarter of 2008. The staff of each hemodi-
alysis unit explained the purpose of the questionnaire, our 
questions, and the discrete visual analog scale to the patients, 
and handed them the questionnaire together with a consent 
form and a return envelope. The data of the entire question-
naire are collected within a quality assurance framework, 
and a specially assigned data protection commissioner 
ensures that patient data are dealt with correctly according 
to German data protection laws. Only data of patients who 
gave written informed consent were considered. The data of 
the questionnaire were all matched to additional data includ-
ing information on sex, age, comorbidities, and time since 
start of hemodialysis, which was provided by an electronic 
patient record by research members of the quality assurance 
program QiN. Only those questionnaires where matching 
was possible were included in the analysis. As the individual 
centers do not keep count of how many questionnaires are 
distributed, it is not possible to calculate a precise response 
rate. The answers to our questions with the discrete visual 
analog scale and additional patient characteristic data were 
then provided by the research members of the QiN group to 
be analyzed.
Data analysis
Descriptive statistics (mean and median scores, standard 
deviations) were used to calculate the ratings of importance 
of outcomes. We ranked the importance of the 23 outcomes 
by mean scores. The results of the rating were also evaluated 
by constructing three summary scores for each outcome. The 
first score – designated “very important” – is the percentage 
of patients who selected the outcome as very important by 
assigning the value 7, 8, or 9 on the discrete visual analog 
scale. The second score – designated “somewhat important” – 
is the percentage of patients who used the values 4, 5, or 6 
on the scale to state their preference for the outcome. The 
third score – “not important” – is the percentage of patients 
who rated the outcome as being not important to them by 
choosing values 1, 2, or 3 on the scale. 
Subgroups of patients were predefined by age (with age cat-
egories of 20 years each, 0–20, 21–40, etc), sex, comorbidity 
(diabetes mellitus), time since start of hemodialysis, 
education (highest school certificates), and profession 
(student, employed, unemployed, or retired). Subgroup 
analysis for the importance of each outcome was performed 
separately using Mann–Whitney U-tests for dichotomous 
data (sex, diabetes) and Kruskal–Wallis tests for categori-
cal data (time since start of hemodialysis, age, education, 
and profession).
To assess the influence of a ceiling effect, which occurs 
when patients rate all outcomes as very important, we 
performed a sensitivity analysis. In this sensitivity analysis, 
all patients who rated all 23 outcomes with a value of 8 
or higher were excluded from the analysis to investigate 
if the overall ratings of the outcomes would change in the 
remaining sample. 
Data analysis was performed using PASW (Predictive 
Analytics SoftWare) Statistics 18 (SPSS Inc., Chicago, IL, 
USA). All analyses are based on response data; no responses 
were imputed.
Results
study population
The survey was returned by 5,666 patients. Of these, 4,518 
questionnaires could successfully be matched to additional 
data as provided by an electronic patient record. The 
calculation of a precise response rate was not possible, but with 
18,000 patients that are treated in the participating hemo-
dialysis centers, it was at least 31%. The respondents did 
not, however, differ from the general population of patients 
with CKD stage V in Germany with regard to age, sex, and 
comorbidities.4 On average, patients were 66.6 years old 
(standard deviation: 5.3) and 58.4% of the patients were 
male. The majority of patients were retired (76%) and 
only 10% were employed. Of those patients who speci-
fied their education, the majority (51%) had a secondary 
level I school, vocational track certificate. On average, 
patients had been treated with hemodialysis for 4.4 years 
(standard deviation: 5.3) and 39.7% of the patients had 
diabetes. Detailed patient characteristics are presented in 
Table 2. 
ratings of outcomes
The mean score of the 23 outcomes ranged between 4.50 
and 8.33 (Table 1). Mean differences between the outcomes 
were rather small and the observed confidence intervals 
were overlapping. The three outcomes rated as most impor-
tant were safety of treatment, health-related quality of life, 
and satisfaction with care. The outcomes rated fourth to 
tenth were related to treatment (individually adjustable 
hemodialysis duration, access to nursing staff during hemo-
dialysis, reduction of traumatic punctures, or prevention 
of nausea/drop in blood pressure during treatment), to the 
reduction of hospital stays, to reduction or prevention of 
accompanying symptoms such as restless leg syndrome or 
insomnia, and to the improvement or preservation of a good 
emotional state.
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ratings of outcomes by subgroups
The most relevant statistically significant differences were 
observed in subgroups characterized by age, profession, 
or education (Table 3). Preferences only differed slightly 
between men and women and patients with or without 
diabetes. The age category 0–20 years consisted of only six 
patients and was therefore not included in further subgroup 
analyses. 
For all three subgroups (age, profession, and education), 
the largest difference in mean ranks as calculated either with 
Kruskal–Wallis or Mann–Whitney U-tests was observed in 
the outcome ability to work despite treatment. It was most 
important to younger patients, to students and the employed, 
and to those with higher education. No need to collaborate 
during treatment was most important to older patients, 
retirees, and – interestingly – those with a higher education. 
Access to medical staff was most important to older and 
retired patients and to those with a lower degree of education 
or with no school leaving certificate.
Age was the only subgroup in which we found a statisti-
cally significant and relevant influence on the subjective 
importance of the outcome life expectancy between differ-
ent categories. A maximum increase in life expectancy was 
most important to younger patients. Also maintaining good 
health-related quality of life and good physical functioning 
was more important to younger patients than to older and to 
retired patients. The ability to choose the nursing staff was 
more important for those with lower education and least 
relevant to patients with a higher education. 
sensitivity analysis
A ceiling effect was observed in 107 patients who rated all 
23 outcomes with 8 or higher. Ranking the aspects after 
exclusion of these patients did not substantially change the 
rank order of the remaining sample.
Discussion
To our knowledge, this study is the first to evaluate patient 
preferences for outcomes in CKD stage V treated with hemo-
dialysis. One of the main findings is that traditional clinical 
outcomes are not clearly prioritized over outcomes related 
to the process of care. 
The most important outcomes to patients were the safety 
of treatment, satisfaction with care at the clinic, and health-
related quality of life. Patients were concerned about receiv-
ing good care, meaning safe treatment and satisfaction with 
care. In contrast, life expectancy was rated as less important 
than one would have expected. This may be due to the fact 
Table 2 Patient characteristics
Patient characteristics Results 
(N=4,518)
Age (years), mean (sD) 66.6 (13.9)
Age categories (years), n (%)
0–20 6 (0.1)
21–40 248 (5.5)
41–60 1,032 (22.8)
61–80 2,611 (57.8)
81–100 621 (13.7)
sex, male (%) 2,640 (58.4)
Diabetes 1,793 (39.7)
Time on hemodialysis (years), mean (sD) 4.4 (5.3)
Time on hemodialysis categories (years), n (%)
0–1 1,446 (32.0)
2–4 1,516 (33.6)
5–10 989 (21.9)
10 421 (9.3)
Not specified 146 (3.2)
Occupation, n (%)
retired 3,421 (75.7)
employed 435 (9.6)
Unemployed 198 (4.4) 
student 26 (0.6)
Not specified 438 (9.7)
education,a n (%)
No school leaving certificate 277 (6.1)
secondary level i school, vocational track  
(hauptschule, 9 years of education) 
2,315 (51.2)
Secondary school level I certificate  
(Mittlere reife, 10 years of education) 
865 (19.1)
General qualification for university entrance  
(Abitur, 12 or 13 years of education)
176 (3.9)
University degree 337 (7.5)
Not specified 548 (12.1)
Note: aAccording to the german school education system. 
importance ratings of outcomes  
The percentages of patients ranking the outcomes as very 
important, somewhat important, and not important are pre-
sented in Figure 1. The outcomes safety, satisfaction, and 
health-related quality of life were rated as very important by 
more than 90% of patients. The ability to work was viewed 
as not important by more than 40% of patients and as very 
important only by approximately 30% of patients. The ability 
to choose nursing or medical staff was rated as very impor-
tant by only around 50% of patients, and about 20% found 
these outcomes to be not important. The access to nursing 
staff was valued as very important by 90%, and less than 4% 
of patients regarded this outcome as not important to them. 
Detailed individual information was valued as very important 
by more than 85%, and as not important by less than 4%. 
Life expectancy was rated very important by nearly 80%, but 
more than 8% valued this outcome as not important.
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Figure 1 Frequency of importance of outcomes. 
Abbreviations: gi, gastrointestinal; hrQol, health-related quality of life.
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that kidney failure has changed from an acute life-threatening 
event to a chronic condition. 
Being on chronic hemodialysis treatment means that 
patients have to cope with a drastic change in everyday life.25 
Consistent with that, the ten outcomes ranked as most impor-
tant in our study were all related to how patients cope in their 
everyday life. Reducing accompanying symptoms, hospital 
stays, nausea, or drop in blood pressure during treatment were 
rated very important. Our findings are consistent with findings 
from other studies which show that hemodialysis treatment 
has a major impact on various domains of life.10,11,26–29 The 
impact seems to be even larger in patients on hemodialysis 
compared to patients on peritoneal dialysis.10,11 
The results of our study show that the possibility of 
individually adjusting the duration of hemodialysis was very 
important to patients. This suggests that patients want to have 
a more active role in their treatment, especially when it is 
time-consuming and impacts on their daily activities. This 
conclusion is supported by other studies which have shown 
similar results.26,30,31 Research projects to optimize shared 
hemodialysis care have been undertaken and emphasize the 
importance patients place on their involvement in care.32–34
strengths and limitations 
The strength of this study is that a comprehensive set of out-
comes was rated by a large group of more than 4,500 patients. 
Although we hypothesized that all outcomes should be 
relevant to patients, as the set of 23 outcomes was chosen 
with the input of patients, the patients were able to rate which 
outcomes were most important to them. The findings of our 
study are relevant for all stakeholders involved in the treat-
ment of chronic renal failure. There are also limitations. 
Owing to the high number of outcomes, we decided to 
use a discrete visual analog scale. The disadvantage of this 
instrument is a ceiling effect. A sensitivity analysis, excluding 
the 107 patients who rated all 23 outcomes with 8 or higher, 
did not result in a different ranking of outcomes. However, 
in the remaining sample, we also observed high ratings for 
a majority of outcomes, indicating that our chosen outcomes 
were indeed very relevant to hemodialysis patients. 
We were not able to estimate if patients had problems 
completing the questionnaire, because there was no record 
of how many questionnaires were distributed to the patients. 
However, rating scales are mostly perceived to be easily 
comprehensible for patients.19 
The electronic patient record only provided data on 
diabetes as comorbidity; we were therefore not able to analyze 
the influence of other comorbidities on the preferences for 
specific outcomes. Furthermore, the rate of retired patients 
was very high in our sample. This has to be acknowledged 
when interpreting the results. A striking example is the rating 
of the ability to work outcome. This outcome was rated as very 
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important by younger patients, but, unsurprisingly, as not so 
important for older patients who were already retired.
relevance to stakeholders
Chronic hemodialysis treatment is a strenuous and time-
consuming treatment for patients. Medical professionals, 
researchers, and operators of hemodialysis clinics should 
be aware that aspects related to the delivery of hemodi-
alysis treatment are very important to patients. This also 
impacts on adherence, which is a key factor for the success 
of treatment.35,36
Conclusion
The beneficial aspects of a hemodialysis treatment in reducing 
mortality and morbidity are not the only outcomes that matter 
to patients. Patients rate the absence of adverse effects of treat-
ments, remaining in a good emotional state and good physical 
functioning, and the accessibility of nursing staff and individual 
information as important outcomes too. Many of the outcomes 
important to patients are currently not applied in research, evalu-
ation studies, or quality programs by default. All stakeholders, 
including researchers, clinic operators, and health professionals, 
should be aware of the values patients place on outcomes and 
incorporate this information into their future work.
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